Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1978-1985
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1978
Table 1 Clinical data of the two groups of patients
VariablesNon-SU group (n = 112)SU group (n = 23)χ2/tP value
Sex, n (%)0.0860.769
    Male67 (59.82)13 (56.52)
    Female45 (40.18)10 (43.48)
Age (yr), n (%)15.062< 0.001
    < 6580 (71.43)6 (26.09)
    ≥ 6532 (28.57)17 (73.91)
Drinking history, n (%)2.2800.131
    Yes46 (41.07)14 (60.87)
    No66 (58.93)9 (39.13)
Smoking history, n (%)0.5130.474
    Yes61 (54.46)15 (65.23)
    No51 (45.54)8 (34.78)
Liver and kidney dysfunction, n (%)2.0350.088
    Yes21 (18.75)8 (34.78)
    No91 (81.25)15 (65.22)
Lymph node metastasis, n (%)14.316< 0.001
    Yes33 (29.46)17 (73.91)
    No79 (70.54)6 (26.09)
Postoperative albumin decreased, n (%)0.2630.608
    < 5028 (25.00)4 (17.39)
    ≥ 5084 (75.00)19 (82.61)
Serum potassium (mmol/L)3.71 ± 0.583.73 ± 0.61-0.1540.878
Hemoglobin (g/L)121.28 ± 16.39115.20 ± 18.520.1150.115
Fasting blood glucose (mmol/L)10.03 ± 4.548.15 ± 3.621.8660.064
CRP (mg/L)72.37 ± 12.0975.32 ± 13.471.0450.298
TNF-α (pg/mL)149.00 ± 18.37151.75 ± 21.410.6350.526
IL-6 (pg/mL)14.46 ± 2.2815.02 ± 3.270.9900.324
IL-8 (pg/mL)18.43 ± 3.4519.82 ± 3.041.7930.075
HSP702.32 ± 0.563.37 ± 0.81-5.876< 0.001
HSP90119.42 ± 17.81159.35 ± 27.37-6.712< 0.001
GAS121.92 ± 29.39146.82 ± 35.36-3.571< 0.001